BioTechnology
Sequentia Biotech Secures 10Million Equity Investment From Seventure Partners And The EIC Fund To Boost Bioinformatic Solutions For Clinical, Industrial And Research Applications
By Business Wire
Share
BARCELONA, Spain--(BUSINESS WIRE)--#AI--Sequentia Biotech, a #deeptech and leading bioinformatics company focused on the analysis and application of omics data, announces a €10million Series A, led by Seventure Partners, a French Venture Capital & Growth investment company with an extensive experience in Life Sciences. The Series A is co-invested by the EIC Fund, the European Commission initiative dedicated to accelerating innovative start-ups across the European Union.
The investment will accelerate Sequentia Biotech’s mission to drive innovation in the field of #omics - the collective characterization and quantification of pools of biological molecules that translate into the structure function and dynamics of an organism(s). Examples of omics include genomics, transcriptomics, epigenomics and microbiomics. The application of omics is driving the development of more precise diagnostic tools in the fields of biomedicine, agritech (e.g. crop protection and nutrition) and in the food industry (e.g. improving food production and quality).
The funds will enable Sequentia Biotech to accelerate the market introduction and expansion of its flagship platform, MICK, and the scale up of its Best-in-Class Bioinformatics Enabling Technologies, driving its ambitious go-to-market strategy. The MICK platform provides state of the art data analysis and interpretation, enabling a deeper exploration of microbiome data and translating it into actionable insights for multiple applications. It has the potential to redefine clinical decision-making, by integrating bioinformatics intelligence around omics into medical practice, biomedical and biopharma applications.
Walter Sanseverino, CEO and Co-Founder at Sequentia Biotech welcomed the funding stating, "We are delighted to announce this fundraising and our backing by Seventure Partners and the EIC Fund, two highly renowned venture capital investors with strong track records in supporting innovative companies in the life sciences sector. This investment will play a major role in advancing our mission to unlock the full potential of omics and accelerate the adoption of MICK by researchers and healthcare professionals globally."
Please refer to the complete press release at the following link: https://www.sequentiabiotech.com/sequentia-biotech-secures-e10million-equity-investment-from-seventure-partners-and-the-eic-fund-to-boost-bioinformatic-solutions-for-clinical-industrial-and-research-applications/
Contacts
Press contacts
SEQUENTIA BIOTECH
Walter Sanseverino
Sequentia Biotech
CEO & Co-Founder
+34-930-10-73-68
wsanseverino@sequentiabiotech.com
Seventure Partners
Isabelle de Cremoux, CEO & managing partner
Tel : +-33-1-57-95-03-77
isabelle.decremoux@seventure.fr
Agence Yucatan
Caroline Prince
Tel : +33-1-53-63-27-35
cprince@yucatan.fr
First published on Mon, Sep 30, 2024
Enjoyed what you read? Great news – there’s a lot more to explore!
Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!
Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.
Head to the TechDogs homepage to Know Your World of technology today!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. All information / content found on TechDogs' site may not necessarily be reviewed by individuals with the expertise to validate its completeness, accuracy and reliability.
Tags:
Related News on BioTechnology
Evonetix Closes $24 Million USD (20 Million) Financing
Tue, Feb 7, 2023
By Business Wire
Kane Biotech Strengthens Board With Biotech Executive
Fri, Nov 17, 2023
By GlobeNewswire
Trinity Life Sciences And WhizAI Announce Partnership
Wed, Apr 26, 2023
By Business Wire
Kiromic BioPharma Announces Uplisting To OTCQB Market
Fri, Nov 17, 2023
By Business Wire
Trending Business Wire
Freecast Launches Youbundle To Simplify Streaming Subscriptions
By Business Wire
Genius Sports Launches Fanhub, Worlds First Advertising & Activation Platform To Reach & Engage Sports Fans
By Business Wire
HPE Positioned As A Leader For Seven Years Running In 2024 Gartner Magic Quadrant For SD-WAN Report
By Business Wire
KUBRA & Silverblaze Partner To Upgrade Billing, Payment, And Customer Engagement Solutions
By Business Wire
MG Digital Direct Expands Multi-Channel Marketing Services With Radisys Engage Digital Platform
By Business Wire
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion